Immuron (IMRN) Change in Receivables (2016 - 2023)
Immuron's quarterly Change in Receivables came in at $2.2 million in Q4 2023, up 281.59% year-on-year from $583772.0 in Q4 2022, and up 281.59% quarter-over-quarter from $583772.0 in Q4 2022.
Immuron has reported Change in Receivables for 6 years, with the latest figure at $2.2 million in Q4 2023.
- For the quarter ending Q4 2023, Change in Receivables rose 281.59% year-over-year to $2.2 million; the trailing twelve-month figure through Dec 2023 stood at $2.4 million (up 1077.92% YoY), and the FY2025 full-year result was $229194.7, up 589.77% from the prior year.
- Change in Receivables for Q4 2023 stood at $2.2 million, up from $583772.0 in the prior quarter.
- The five-year high for Change in Receivables was $2.2 million in Q4 2023, with the low at -$353939.0 in Q2 2022.
- Average Change in Receivables over 4 years is $486659.0, with a median of $10549.7 recorded in 2020.
- Year-over-year, Change in Receivables plunged 919.92% in 2022 and soared 281.59% in 2023.
- Tracing IMRN's Change in Receivables over 4 years: stood at $10549.7 in 2020, then plunged by 428.94% to -$34702.5 in 2021, then surged by 1782.22% to $583772.0 in 2022, then soared by 281.59% to $2.2 million in 2023.
- The last three Change in Receivables figures came in at $2.2 million (Q4 2023), $583772.0 (Q4 2022), and -$353939.0 (Q2 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 208,524.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -39.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 110.42 Mn |
| 10 | Immuron | 1.27 Bn | 1.27 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 2.23 Mn |
| Dec 31, 2023 | 2.23 Mn |
| Dec 31, 2022 | 583,772.00 |
| Dec 31, 2022 | 583,772.00 |
| Jun 30, 2022 | -353,938.98 |
| Jun 30, 2022 | -353,938.98 |
| Jun 30, 2021 | -34,702.53 |
| Jun 30, 2021 | -34,702.53 |
| Jun 30, 2020 | 10,549.65 |
| Jun 30, 2020 | 10,549.65 |
| Dec 31, 2017 | 923,408.71 |
| Dec 31, 2017 | 923,408.71 |
| Dec 31, 2016 | 501,319.99 |
| Dec 31, 2016 | 501,319.99 |